Study to Assess the Efficacy and Safety of Raxone in LHON Patients
Status:
Completed
Trial end date:
2021-03-29
Target enrollment:
Participant gender:
Summary
LEROS is an open-label interventional Phase IV study, designed to further assess the efficacy
and safety of Raxone® in the long-term treatment of LHON patients.